相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The role of routine imaging procedures in the detection of relapse of patients with Hodgkin lymphoma and aggressive non-Hodgkin lymphoma
Neta Goldschmidt et al.
ANNALS OF HEMATOLOGY (2011)
CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group
Michael Pfreundschuh et al.
LANCET ONCOLOGY (2011)
Routine follow-up scanning of patients with lymphoma: who, when, how, and why?
Martin Hutchings
LEUKEMIA & LYMPHOMA (2011)
Efficacy of routine surveillance with positron emission tomography/computed tomography in aggressive non-Hodgkin lymphoma in complete remission: status in a single center
Tarec El-Galaly et al.
LEUKEMIA & LYMPHOMA (2011)
Risk-adapted FDG-PET/CT-based follow-up in patients with diffuse large B-cell lymphoma after first-line therapy
U. Petrausch et al.
ANNALS OF ONCOLOGY (2010)
Diffuse large B-cell non-Hodgkin's lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
H. Tilly et al.
ANNALS OF ONCOLOGY (2010)
Salvage Regimens With Autologous Transplantation for Relapsed Large B-Cell Lymphoma in the Rituximab Era
Christian Gisselbrecht et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
High incidence of false-positive PET scans in patients with aggressive non-Hodgkin's lymphoma treated with rituximab-containing regimens
H. S. Han et al.
ANNALS OF ONCOLOGY (2009)
Role of [18F] Fluorodeoxyglucose Positron Emission Tomography Scan in the Follow-Up of Lymphoma
Pier Luigi Zinzani et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
The Case Against Heavy PETing
Bruce Cheson
JOURNAL OF CLINICAL ONCOLOGY (2009)
Bronchus-associated lymphoid tissue lymphomas: An update of a rare extranodal maltoma
Pier Luigi Zinzani et al.
CLINICAL LYMPHOMA & MYELOMA (2007)
The international prognostic index assessed at relapse predicts outcomes of autologous transplantation for diffuse large-cell non-Hodgkin's lymphoma in second complete or partial remission
Rachel E. Lerner et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2007)
Revised response criteria for malignant lymphoma
Bruce D. Cheson et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Surveillance imaging during remission identifies a group of patients with more favorable aggressive NHL at time of relapse: a retrospective analysis of a uniformly-treated patient population
M. Liedtke et al.
ANNALS OF ONCOLOGY (2006)
Computed tomography and 18F-FDG positron emission tomography for therapy control of Hodgkin's and non-Hodgkin's lymphoma patients:: when do we really need FDG-PET?
MJ Reinhardt et al.
ANNALS OF ONCOLOGY (2005)
A metaanalysis of 18F-2-deoxy-2-fluoro-D-glucose positron emission tomography in the staging and restaging of patients with lymphoma
CR Isasi et al.
CANCER (2005)
[18F]fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in aggressive lymphoma:: an early prognostic tool for predicting patient outcome
C Haioun et al.
BLOOD (2005)
Introduction of combined CHOP plus rituximab therapy dramatically improved outcome of diffuse large B-cell lymphoma in British Columbia
LH Sehn et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
FDG pet in the follow-up management of patients with newly diagnosed Hodgkin and non-Hodgkin lymphoma after first-line chemotherapy
WC Lavely et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2003)
Age-adjusted International Prognostic Index predicts autologous stem cell transplantation outcome for patients with relapsed or primary refractory diffuse large B-cell lymphoma
PA Hamlin et al.
BLOOD (2003)
The role of surveillance CT scans in patients with diffuse large B-cell non-Hodgkin's lymphoma
AE Guppy et al.
LEUKEMIA & LYMPHOMA (2003)
Accuracy of whole-body F-18-FDP-PET for restaging malignant lymphoma
P Mikosch et al.
ACTA MEDICA AUSTRIACA (2003)
Early restaging positron emission tomography with 18F-fluorodeoxyglucose predicts outcome in patients with aggressive non-Hodgkin's lymphoma
K Spaepen et al.
ANNALS OF ONCOLOGY (2002)
Advantages of positron emission tomography (PET) with respect to computed tomography in the follow-up of lymphoma patients with abdominal presentation
PL Zinzani et al.
LEUKEMIA & LYMPHOMA (2002)
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
B Coiffier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Detection of relapse in non-Hodgkin's lymphoma: Role of routine follow-up studies
A Elis et al.
AMERICAN JOURNAL OF HEMATOLOGY (2002)
Can positron emission tomography with [18F]-fluorodeoxyglucose after first-line treatment distinguish Hodgkin's disease patients who need additional therapy from others in whom additional therapy would mean avoidable toxicity?
K Spaepen et al.
BRITISH JOURNAL OF HAEMATOLOGY (2001)
Prognostic value of positron emission tomography (PET) with fluorine-18 fluorodeoxyglucose ([18F]FDG) after first-line chemotherapy in non-Hodgkin's lymphoma:: Is [18F]FDG-PET a valid alternative to conventional diagnostic methods?
K Spaepen et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
18-FDG-PET as a prognostic indicator in the treatment of aggressive non-Hodgkin's lymphoma-comparison with CT
NG Mikhaeel et al.
LEUKEMIA & LYMPHOMA (2000)
Fluorine-18 fluorodeoxyglucose positron emission tomography in the staging and follow-up of lymphoma: is it time to shift gears?
L Kostakoglu et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE (2000)
分享论文
